Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Vedolizumab +/− Etanercept for Type 1 Diabetes
Recruiting2 awardsPhase < 1
La Jolla, California
This trial will test whether a drug called vedolizumab, used to treat Crohn's disease and ulcerative colitis, can also be used to treat type 1 diabetes. The trial will also test whether pretreating with another drug, etanercept, can enhance vedolizumab's effectiveness.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.